Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo

Por Malmström, Rickard E
Publicado em 2001

The neuropeptide Y (NPY) Y(1) receptor antagonist BIBP 3226: effects on vascular responses to exogenous and endogenous NPY in the pig in vivo

Por Malmström, Rickard E, Balmér, Karin C, Lundberg, Jan M
Publicado em 1997

Persistence with dimethyl fumarate in relapsing-remitting multiple sclerosis: a population-based cohort study

Por Eriksson, Irene, Cars, Thomas, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Publicado no Eur J Clin Pharmacol (2017)

The changing multiple sclerosis treatment landscape: impact of new drugs and treatment recommendations

Por Eriksson, Irene, Komen, Joris, Piehl, Fredrik, Malmström, Rickard E., Wettermark, Björn, von Euler, Mia
Publicado no Eur J Clin Pharmacol (2018)

Sex differences in spontaneous reports on adverse drug events for common antihypertensive drugs

Por Rydberg, Diana M, Mejyr, Stefan, Loikas, Desirée, Schenck-Gustafsson, Karin, von Euler, Mia, Malmström, Rickard E
Publicado no Eur J Clin Pharmacol (2018)

The Early Awareness and Alert System in Sweden: History and Current Status

Por Eriksson, Irene, Wettermark, Björn, Persson, Marie, Edström, Morgan, Godman, Brian, Lindhé, Anna, Malmström, Rickard E., Ramström, Helena, von Euler, Mia, Bergkvist Christensen, Anna
Publicado no Front Pharmacol (2017)

Different initiatives across Europe to enhance losartan utilization post generics: impact and implications

Por Moon, James C., Godman, Brian, Petzold, Max, Alvarez-Madrazo, Samantha, Bennett, Kathleen, Bishop, Iain, Bucsics, Anna, Hesse, Ulrik, Martin, Andrew, Simoens, Steven, Zara, Corinne, Malmström, Rickard E.
Publicado em 2014

High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines

Por Eriksen, Jaran, Gustafsson, Lars L, Ateva, Kristina, Bastholm-Rahmner, Pia, Ovesjö, Marie-Louise, Jirlow, Malena, Juhasz-Haverinen, Maria, Lärfars, Gerd, Malmström, Rickard E, Wettermark, Björn, Andersén-Karlsson, Eva
Publicado no BMJ Open (2017)

Patients’ knowledge and attitudes to the Wise List - a drug formulary from the Stockholm Drug and Therapeutic committee

Por Bastholm-Rahmner, Pia, Gustafsson, Lars L., Aggefors, Kristina, Ateva, Kristina, Elfving, Susanne, Eriksen, Jaran, Jirlow, Malena, Juhasz-Haverinen, Maria, Malmström, Rickard E., Nikpour-Ardaly, Mahan, Röjvall, Magnus, Vallin, Martina, Andersén-Karlsson, Eva, Ovesjö, Marie-Louise
Publicado no BMC Health Serv Res (2018)

Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications

Por Godman, Brian, Shrank, William, Andersen, Morten, Berg, Christian, Bishop, Iain, Burkhardt, Thomas, Garuoliene, Kristina, Herholz, Harald, Joppi, Roberta, Kalaba, Marija, Laius, Ott, Lonsdale, Julie, Malmström, Rickard E., Martikainen, Jaana E., Samaluk, Vita, Sermet, Catherine, Schwabe, Ulrich, Teixeira, Inês, Tilson, Lesley, Tulunay, F. Cankat, Vlahović-Palčevski, Vera, Wendykowska, Kamila, Wettermark, Bjorn, Zara, Corinne, Gustafsson, Lars L.
Publicado em 2011

Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs

Por Godman, Brian, Malmström, Rickard E., Diogene, Eduardo, Jayathissa, Sisira, McTaggart, Stuart, Cars, Thomas, Alvarez-Madrazo, Samantha, Baumgärtel, Christoph, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Eriksson, Irene, Finlayson, Alexander, Fürst, Jurij, Garuoliene, Kristina, Gutiérrez-Ibarluzea, Iñaki, Hviding, Krystyna, Herholz, Harald, Joppi, Roberta, Kalaba, Marija, Laius, Ott, Malinowska, Kamila, Pedersen, Hanne B., Markovic-Pekovic, Vanda, Piessnegger, Jutta, Selke, Gisbert, Sermet, Catherine, Spillane, Susan, Tomek, Dominik, Vončina, Luka, Vlahović-Palčevski, Vera, Wale, Janet, Wladysiuk, Magdalena, van Woerkom, Menno, Zara, Corinne, Gustafsson, Lars L.
Publicado em 2014

Personalizing health care: feasibility and future implications

Por Godman, Brian, Finlayson, Alexander E, Cheema, Parneet K, Zebedin-Brandl, Eva, Gutiérrez-Ibarluzea, Inaki, Jones, Jan, Malmström, Rickard E, Asola, Elina, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Bucsics, Anna, Campbell, Stephen, Diogene, Eduardo, Ferrario, Alessandra, Fürst, Jurij, Garuoliene, Kristina, Gomes, Miguel, Harris, Katharine, Haycox, Alan, Herholz, Harald, Hviding, Krystyna, Jan, Saira, Kalaba, Marija, Kvalheim, Christina, Laius, Ott, Lööv, Sven-Ake, Malinowska, Kamila, Martin, Andrew, McCullagh, Laura, Nilsson, Fredrik, Paterson, Ken, Schwabe, Ulrich, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Tomek, Dominik, Vlahovic-Palcevski, Vera, Voncina, Luka, Wladysiuk, Magdalena, van Woerkom, Menno, Wong-Rieger, Durhane, Zara, Corrine, Ali, Raghib, Gustafsson, Lars L
Publicado em 2013

Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

Por Malmström, Rickard E., Godman, Brian B., Diogene, Eduard, Baumgärtel, Christoph, Bennie, Marion, Bishop, Iain, Brzezinska, Anna, Bucsics, Anna, Campbell, Stephen, Ferrario, Alessandra, Finlayson, Alexander E., Fürst, Jurij, Garuoliene, Kristina, Gomes, Miguel, Gutiérrez-Ibarluzea, Iñaki, Haycox, Alan, Hviding, Krystyna, Herholz, Harald, Hoffmann, Mikael, Jan, Saira, Jones, Jan, Joppi, Roberta, Kalaba, Marija, Kvalheim, Christina, Laius, Ott, Langner, Irene, Lonsdale, Julie, Lööv, Sven-Äke, Malinowska, Kamila, McCullagh, Laura, Paterson, Ken, Markovic-Pekovic, Vanda, Martin, Andrew, Piessnegger, Jutta, Selke, Gisbert, Sermet, Catherine, Simoens, Steven, Tulunay, Cankat, Tomek, Dominik, Vončina, Luka, Vlahovic-Palcevski, Vera, Wale, Janet, Wilcock, Michael, Wladysiuk, Magdalena, van Woerkom, Menno, Zara, Corrine, Gustafsson, Lars L.
Publicado em 2013